An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Proteomics

• Publication date

  2016-10-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jprot.2016.07.032PMID 27498392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.

  2015cited by this paper
• Filopodia formation driven by membrane glycoprotein M6a depends on the interaction of its transmembrane domains

  2015cited by this paper
• Brain tocopherols related to Alzheimer's disease neuropathology in humans

  2015cited by this paper
• Mitochondrial dynamics and inherited peripheral nerve diseases.

  2015cited by this paper
• Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species

  2015cited by this paper
• Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers

  2015cited by this paper
• Tyrosine 251 at the C‐terminus of neuronal glycoprotein M6a is critical for neurite outgrowth

  2015cited by this paper
• Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer’s Disease-Like Pathology, Blood–Brain Barrier Disruption, and Synaptic Disorder

  2015cited by this paper
• Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies

  2015cited by this paper
• Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: a histological perspective

  2015cited by this paper
• Cell type– and brain region–resolved mouse brain proteome

  2015cited by this paper
• Role of hydrogen sulfide in brain synaptic remodeling.

  2015cited by this paper
• Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers

  2015cited by this paper
• Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice

  2015cited by this paper
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

  2014cited by this paper
• ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination

  2014cited by this paper
• Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.

  2014cited by this paper
• Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.

  2014cited by this paper
• 1H NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease

  2014cited by this paper
• Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease

  2014cited by this paper
• Olfactory bulb involvement in neurodegenerative diseases

  2014cited by this paper
• Primary age-related tauopathy (PART): a common pathology associated with human aging

  2014cited by this paper
• Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing

  2014cited by this paper
• The diverse roles and multiple forms of focal adhesion kinase in brain

  2014cited by this paper
• Proteome characterization of splenocytes from an Aβpp/ps‐1 Alzheimer's disease model

  2014cited by this paper
• Contribution of cysteine aminotransferase and mercaptopyruvate sulfurtransferase to hydrogen sulfide production in peripheral neurons

  2014cited by this paper
• Early and sustained altered expression of aging-related genes in young 3xTg-AD mice

  2014cited by this paper
• Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.

  2014cited by this paper
• Coactosin-Like 1 Antagonizes Cofilin to Promote Lamellipodial Protrusion at the Immune Synapse

  2014cited by this paper
• Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer’s disease

  2013cited by this paper
• Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

  2013cited by this paper
• Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model.

  2013cited by this paper
• Novel genes that mediate nuclear respiratory factor 1-regualted neurite outgrowth in neuroblastoma IMR-32 cells.

  2013cited by this paper
• Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry.

  2012cited by this paper
• Behavioral and cellular markers of olfactory aging and their response to enrichment.

  2012cited by this paper
• Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.

  2012cited by this paper
• PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance

  2012cited by this paper
• Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease

  2012cited by this paper
• Loss of Prohibitin Membrane Scaffolds Impairs Mitochondrial Architecture and Leads to Tau Hyperphosphorylation and Neurodegeneration

  2012cited by this paper
• Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid β oligomers.

  2012cited by this paper
• Comparison of extraction methods for the comprehensive analysis of mouse brain proteome using shotgun-based mass spectrometry.

  2012cited by this paper
• Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

  2011cited by this paper
• The C terminus of talin links integrins to cell cycle progression

  2011cited by this paper
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

  2011cited by this paper
• Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications

  2011cited by this paper
• High doses of vitamin E improve mitochondrial dysfunction in rat hippocampus and frontal cortex upon aging.

  2011cited by this paper
• Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

  2011cited by this paper
• Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease

  2010cited by this paper
• Current status on Alzheimer disease molecular genetics: from past, to present, to future

  2010cited by this paper
• Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease

  2010cited by this paper
• Filopodial protrusions induced by glycoprotein M6a exhibit high motility and aids synapse formation

  2010cited by this paper
• Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles.

  2010cited by this paper
• α-Tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines.

  2010cited by this paper
• A possible role of myristoylated alanine-rich C kinase substrate in endocytic pathway of Alzheimer’s disease

  2010cited by this paper
• Alpha-Tocopherol Decreases Iron-Induced Hippocampal and Nigral Neuron Loss

  2010cited by this paper
• Pharmacology of the intracellular pathways activated by amyloid beta protein.

  2009cited by this paper
• Prohibitin and mitochondrial biology.

  2009cited by this paper
• Presenilin 1 Affects Focal Adhesion Site Formation and Cell Force Generation via c-Src Transcriptional and Posttranslational Regulation*

  2009cited by this paper
• Amyloid- (cid:1) and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice

  2009cited by this paper
• Depletion of Vitamin E Increases Amyloid β Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease*

  2009cited by this paper
• Dynein Light Chain LC8 Regulates Syntaphilin-Mediated Mitochondrial Docking in Axons

  2009cited by this paper
• 3-Mercaptopyruvate Sulfurtransferase Produces Hydrogen Sulfide and Bound Sulfane Sulfur in the Brain

  2009cited by this paper
• MAPK, β-amyloid and synaptic dysfunction: the role of RAGE

  2009cited by this paper
• Abnormal cleavage of APP impairs its functions in cell adhesion and migration.

  2009cited by this paper
• Focal adhesion kinase modulates cell adhesion strengthening via integrin activation.

  2009cited by this paper
• Presenilin regulates extracellular regulated kinase (Erk) activity by a protein kinase C alpha dependent mechanism.

  2008cited by this paper
• Animal Models of Alzheimer's Disease: Therapeutic Implications

  2008cited by this paper
• iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease

  2008cited by this paper
• Nonlinear fitting method for determining local false discovery rates from decoy database searches.

  2008cited by this paper
• Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease

  2008cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism

  2008cited by this paper
• Characterization of three human sec14p-like proteins: alpha-tocopherol transport activity and expression pattern in tissues.

  2008cited by this paper
• The catalytic core of gamma-secretase: presenilin revisited.

  2008cited by this paper
• Synaptic vesicle endocytosis: fast and slow modes of membrane retrieval.

  2008cited by this paper
• Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease.

  2007cited by this paper
• The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S

  2007cited by this paper
• Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

  2006cited by this paper
• Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

  2006cited by this paper
• B56‐containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX‐1 and ERK

  2006cited by this paper
• In-gel digestion for mass spectrometric characterization of proteins and proteomes

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism

  2006cited by this paper
• Endofin recruits clathrin to early endosomes via TOM1

  2005cited by this paper
• A novel GTPase-activating protein for ARF6 directly interacts with clathrin and regulates clathrin-dependent endocytosis.

  2005cited by this paper
• Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.

  2005cited by this paper
• ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3

  2004cited by this paper
• Emerging Role for ERK as a Key Regulator of Neuronal Apoptosis

  2004cited by this paper
• Induction of protein kinase C substrates, Myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP), by amyloid beta-protein in mouse BV-2 microglial cells.

  2003cited by this paper
• Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice.

  2003cited by this paper
• Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice

  2003cited by this paper
• Aberrant Activation of Focal Adhesion Proteins Mediates Fibrillar Amyloid β-Induced Neuronal Dystrophy

  2003cited by this paper
• Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways

  2002cited by this paper
• Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain*

  2002cited by this paper
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002cited by this paper
• Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases

  2002cited by this paper
• Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages

  2001cited by this paper
• Phosphorylation of MARCKS in Alzheimer disease brains

  2000cited by this paper
• β‐Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease

  1999cited by this paper
• A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate

  1997cited by this paper

• Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015–2023

  2025cites this paper
• A microglia clonal inflammatory disorder in Alzheimer’s disease

  2025cites this paper
• Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease

  2024cites this paper
• Intestinal homeostasis disrupted by Periodontitis exacerbates Alzheimer’s Disease in APP/PS1 mice

  2024cites this paper
• Early detection of Alzheimer's disease using the MEMORIES mnemonic

  2024cites this paper
• Olfactory Dysfunction and Alzheimer’s Disease: A Review

  2024cites this paper
• Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease

  2024cites this paper
• The structure of an amyloid precursor protein/talin complex indicates a mechanical basis of Alzheimer’s disease

  2024cites this paper
• A microglia clonal inflammatory disorder in Alzheimer’s Disease

  2024cites this paper
• Role of miR‐124‐3p in regulatory mechanisms of Gpm6a expression in the hippocampus of chronically stressed rats

  2023cites this paper
• Non-conducting functions of potassium channels in cancer and neurological disease.

  2023cites this paper
• Optimization of Enterotoxigenic Escherichia coli (ETEC) Outer Membrane Vesicles Production and Isolation Method for Vaccination Purposes

  2023cites this paper
• Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI‐MSI

  2023cites this paper
• Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

  2022cites this paper
• RNA hypomethylation and unchanged DNA methylation levels in the cortex of ApoE4 carriers and Alzheimer's disease subjects.

  2022cites this paper
• Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model

  2022cites this paper
• Conserved cell‐type specific signature of resilience to Alzheimer’s disease nominates role for excitatory cortical neurons

  2022cites this paper
• Deep Scoring Neural Network Replacing the Scoring Function Components to Improve the Performance of Structure-Based Molecular Docking.

  2021cites this paper
• REW-ISA V2: A Biclustering Method Fusing Homologous Information for Analyzing and Mining Epi-Transcriptome Data

  2021cites this paper
• Neuronal Glycoprotein M6a: An Emerging Molecule in Chemical Synapse Formation and Dysfunction

  2021cites this paper
• Olfactory impairment in men and mice related to aging and amyloid-induced pathology

  2021cites this paper
• Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein

  2021cites this paper
• Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer’s disease mouse model

  2021cites this paper
• The prohibitin complex in aging and neurodegeneration

  2021cites this paper
• Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes

  2021cites this paper
• Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies

  2020cites this paper
• Noise exposure accelerates the risk of cognitive impairment and Alzheimer's disease: Adulthood, gestational, and prenatal mechanistic evidence from animal studies.

  2020cites this paper
• Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases

  2020cites this paper
• Identification of Potential Interacting Proteins With the Extracellular Loops of the Neuronal Glycoprotein M6a by TMT/MS

  2020cites this paper
• Smelling the Dark Proteome: Functional Characterization of PITH Domain-Containing Protein 1 (C1orf128) in Olfactory Metabolism.

  2020cites this paper
• Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM

  2020cites this paper
• Impairment of Dendrodendritic Inhibition in the Olfactory Bulb of APP/PS1 Mice

  2019cites this paper
• Olfactory proteotyping: towards the enlightenment of the neurodegeneration

  2019cites this paper
• Animal models of olfactory dysfunction in neurodegenerative diseases.

  2019cites this paper
• The Human Brain Proteome Project: Biological and Technological Challenges.

  2019cites this paper
• Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.

  2019cites this paper
• Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.

  2019cites this paper
• Commentary on Giralt et al.: PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease

  2019cites this paper
• Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer’s Disease

  2019cites this paper
• Molecular Inverse Comorbidity between Alzheimer’s Disease and Lung Cancer: New Insights from Matrix Factorization

  2019cites this paper
• The olfactory bulb proteotype differs across frontotemporal dementia spectrum.

  2019cites this paper
• “Till Death Do Us Part”: A Potential Irreversible Link Between Aberrant Cell Cycle Control and Neurodegeneration in the Adult Olfactory Bulb

  2018cites this paper
• FAK family kinases in brain health and disease

  2018cites this paper
• O-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes

  2018cites this paper
• Gestational Stress Augments Postpartum β-Amyloid Pathology and Cognitive Decline in a Mouse Model of Alzheimer's Disease.

  2018cites this paper
• Towards a subunit vaccine from a Shigella flexneri ΔtolR mutant.

  2018cites this paper
• Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells.

  2018cites this paper
• Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition

  2018cites this paper
• Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer’s Disease Mice

  2018cites this paper
• Injected Amyloid Beta in the Olfactory Bulb Transfers to Other Brain Regions via Neural Connections in Mice

  2017cites this paper
• PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β

  2017cites this paper
• Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?

  2017cites this paper
• The Membrane Glycoprotein M6a Endocytic/Recycling Pathway Involves Clathrin-Mediated Endocytosis and Affects Neuronal Synapses

  2017cites this paper
• Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer’s Disease Mouse Model

  2017cites this paper
• Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression

  2017cites this paper
• Measuring Olfactory Processes in Mus musculus.

  2017cites this paper
• Amyloid-beta immunotherapy: the hope for Alzheimer disease?

  2016cites this paper